Skip to main content
PMC home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1996 Aug 1;134(3):757–770. doi: 10.1083/jcb.134.3.757

Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity

PMCID: PMC2120941  PMID: 8707853

Abstract

Camptothecin is an S-phase-specific anticancer agent that inhibits the activity of the enzyme DNA topoisomerase-I (topo-I). Irreversible DNA double-strand breaks are produced during DNA synthesis in the presence of camptothecin, suggesting that this agent should not be toxic to nondividing cells, such as neurons. Unexpectedly, camptothecin induced significant, dose-dependent cell death of postmitotic rat cortical neurons in vitro; astrocytes were more resistant. Aphidicolin, an inhibitor of DNA polymerase alpha, did not prevent camptothecin-induced neuronal death, while death was prevented by actinomycin D and 5,6- dichloro-1-beta-D-ribofuranosyl benzimidazole as well as cycloheximide and anisomycin, inhibitors of RNA and protein synthesis, respectively. Camptothecin-induced neuronal death was apoptotic, as characterized by chromatin condensation, cytoplasmic shrinking, plasma membrane blebbing, and fragmentation of neurites. DNA fragmentation was also confirmed by the use of the in situ DNA end labeling assay. In addition, aurintricarboxylic acid, an inhibitor of the apoptotic endonuclease, partially protected against camptothecin-induced neuronal death. The toxicity of stereoisomers of a camptothecin analogue was stereospecific, demonstrating that toxicity was a result of inhibition of topo-I. The difference in sensitivity to camptothecin between neurons and astrocytes correlated with their transcriptional activity and level of topo-I protein expression. These data indicate important roles for topo-I in postmitotic neurons and suggest that topo-I inhibitors can induce apoptosis independent of DNA synthesis. We suggest a model based on transcriptionally mediated DNA damage, a novel mechanism of action of topo-I poisons.

Full Text

The Full Text of this article is available as a PDF (2.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basma A. N., Morris E. J., Nicklas W. J., Geller H. M. L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J Neurochem. 1995 Feb;64(2):825–832. doi: 10.1046/j.1471-4159.1995.64020825.x. [DOI] [PubMed] [Google Scholar]
  2. Batistatou A., Greene L. A. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J Cell Biol. 1991 Oct;115(2):461–471. doi: 10.1083/jcb.115.2.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bendixen C., Thomsen B., Alsner J., Westergaard O. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Biochemistry. 1990 Jun 12;29(23):5613–5619. doi: 10.1021/bi00475a028. [DOI] [PubMed] [Google Scholar]
  4. Bertrand R., Solary E., Jenkins J., Pommier Y. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp Cell Res. 1993 Aug;207(2):388–397. doi: 10.1006/excr.1993.1206. [DOI] [PubMed] [Google Scholar]
  5. Bruno S., Lassota P., Giaretti W., Darzynkiewicz Z. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases. Oncol Res. 1992;4(1):29–35. [PubMed] [Google Scholar]
  6. Chatterjee S., Cheng M. F., Trivedi D., Petzold S. J., Berger N. A. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun. 1989;1(6):389–394. doi: 10.3727/095535489820875129. [DOI] [PubMed] [Google Scholar]
  7. Chen A. Y., Liu L. F. DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol. 1994;34:191–218. doi: 10.1146/annurev.pa.34.040194.001203. [DOI] [PubMed] [Google Scholar]
  8. Chodosh L. A., Fire A., Samuels M., Sharp P. A. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J Biol Chem. 1989 Feb 5;264(4):2250–2257. [PubMed] [Google Scholar]
  9. Chopp M., Chan P. H., Hsu C. Y., Cheung M. E., Jacobs T. P. DNA damage and repair in central nervous system injury: National Institute of Neurological Disorders and Stroke Workshop Summary. Stroke. 1996 Mar;27(3):363–369. doi: 10.1161/01.str.27.3.363. [DOI] [PubMed] [Google Scholar]
  10. Clarke D. W., Boyd F. T., Jr, Kappy M. S., Raizada M. K. Insulin stimulates macromolecular synthesis in cultured glial cells from rat brain. Am J Physiol. 1985 Nov;249(5 Pt 1):C484–C489. doi: 10.1152/ajpcell.1985.249.5.C484. [DOI] [PubMed] [Google Scholar]
  11. Cohen J. J., Duke R. C., Fadok V. A., Sellins K. S. Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992;10:267–293. doi: 10.1146/annurev.iy.10.040192.001411. [DOI] [PubMed] [Google Scholar]
  12. Cotter T. G., Glynn J. M., Echeverri F., Green D. R. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 1992 May-Jun;12(3):773–779. [PubMed] [Google Scholar]
  13. D'Arpa P., Beardmore C., Liu L. F. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 1990 Nov 1;50(21):6919–6924. [PubMed] [Google Scholar]
  14. D'Arpa P. Determinants of cellular sensitivity to topoisomerase-targeting antitumor drugs. Adv Pharmacol. 1994;29B:127–143. doi: 10.1016/s1054-3589(08)61135-7. [DOI] [PubMed] [Google Scholar]
  15. D'Mello S. R., Galli C., Ciotti T., Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10989–10993. doi: 10.1073/pnas.90.23.10989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Deckwerth T. L., Johnson E. M., Jr Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol. 1993 Dec;123(5):1207–1222. doi: 10.1083/jcb.123.5.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Del Bino G., Bruno S., Yi P. N., Darzynkiewicz Z. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Prolif. 1992 Nov;25(6):537–548. doi: 10.1111/j.1365-2184.1992.tb01458.x. [DOI] [PubMed] [Google Scholar]
  18. Dessi F., Pollard H., Moreau J., Ben-Ari Y., Charriaut-Marlangue C. Cytosine arabinoside induces apoptosis in cerebellar neurons in culture. J Neurochem. 1995 May;64(5):1980–1987. doi: 10.1046/j.1471-4159.1995.64051980.x. [DOI] [PubMed] [Google Scholar]
  19. Dubrez L., Goldwasser F., Genne P., Pommier Y., Solary E. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia. 1995 Jun;9(6):1013–1024. [PubMed] [Google Scholar]
  20. Dwyer B. E., Nishimura R. N., Lu S. Y. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res. 1995 May;30(1):37–47. doi: 10.1016/0169-328x(94)00273-h. [DOI] [PubMed] [Google Scholar]
  21. Eng W. K., Faucette L., Johnson R. K., Sternglanz R. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol Pharmacol. 1988 Dec;34(6):755–760. [PubMed] [Google Scholar]
  22. Flangas A. L., Bowman R. E. Differential metabolism of RNA in neuronal-enriched and glial-enriched fractions of rat cerebrum. J Neurochem. 1970 Aug;17(8):1237–1245. doi: 10.1111/j.1471-4159.1970.tb03373.x. [DOI] [PubMed] [Google Scholar]
  23. Gorczyca W., Gong J., Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 1993 Apr 15;53(8):1945–1951. [PubMed] [Google Scholar]
  24. Hartley A., Stone J. M., Heron C., Cooper J. M., Schapira A. H. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem. 1994 Nov;63(5):1987–1990. doi: 10.1046/j.1471-4159.1994.63051987.x. [DOI] [PubMed] [Google Scholar]
  25. Hickson I. D., Davies S. L., Davies S. M., Robson C. N. DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases. Int J Radiat Biol. 1990 Oct;58(4):561–568. doi: 10.1080/09553009014551921. [DOI] [PubMed] [Google Scholar]
  26. Hsiang Y. H., Hertzberg R., Hecht S., Liu L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 1985 Nov 25;260(27):14873–14878. [PubMed] [Google Scholar]
  27. Hsiang Y. H., Lihou M. G., Liu L. F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 1989 Sep 15;49(18):5077–5082. [PubMed] [Google Scholar]
  28. Hwang J., Hwong C. L. Cellular regulation of mammalian DNA topoisomerases. Adv Pharmacol. 1994;29A:167–189. doi: 10.1016/s1054-3589(08)60545-1. [DOI] [PubMed] [Google Scholar]
  29. Johnson E. M., Jr, Deckwerth T. L. Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci. 1993;16:31–46. doi: 10.1146/annurev.ne.16.030193.000335. [DOI] [PubMed] [Google Scholar]
  30. Kessel D. Effects of camptothecin on RNA synthesis in leukemia L1210 cells. Biochim Biophys Acta. 1971 Aug 26;246(2):225–232. doi: 10.1016/0005-2787(71)90131-6. [DOI] [PubMed] [Google Scholar]
  31. Koh J. Y., Wie M. B., Gwag B. J., Sensi S. L., Canzoniero L. M., Demaro J., Csernansky C., Choi D. W. Staurosporine-induced neuronal apoptosis. Exp Neurol. 1995 Oct;135(2):153–159. doi: 10.1006/exnr.1995.1074. [DOI] [PubMed] [Google Scholar]
  32. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  33. Leadon S. A., Cooper P. K. Preferential repair of ionizing radiation-induced damage in the transcribed strand of an active human gene is defective in Cockayne syndrome. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10499–10503. doi: 10.1073/pnas.90.22.10499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lowe S. W., Ruley H. E., Jacks T., Housman D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993 Sep 24;74(6):957–967. doi: 10.1016/0092-8674(93)90719-7. [DOI] [PubMed] [Google Scholar]
  35. Madden K. R., Champoux J. J. Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res. 1992 Feb 1;52(3):525–532. [PubMed] [Google Scholar]
  36. Martin D. P., Schmidt R. E., DiStefano P. S., Lowry O. H., Carter J. G., Johnson E. M., Jr Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol. 1988 Mar;106(3):829–844. doi: 10.1083/jcb.106.3.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mizuguchi M., Ikeda K., Asada M., Mizutani S., Kamoshita S. Expression of Bcl-2 protein in murine neural cells in culture. Brain Res. 1994 Jun 27;649(1-2):197–202. doi: 10.1016/0006-8993(94)91064-2. [DOI] [PubMed] [Google Scholar]
  38. Morrison R. S., de Vellis J. Growth of purified astrocytes in a chemically defined medium. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7205–7209. doi: 10.1073/pnas.78.11.7205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  40. Muller M. T., Pfund W. P., Mehta V. B., Trask D. K. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J. 1985 May;4(5):1237–1243. doi: 10.1002/j.1460-2075.1985.tb03766.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nakajima M., Kashiwagi K., Ohta J., Furukawa S., Hayashi K., Kawashima T., Hayashi Y. Etoposide induces programmed death in neurons cultured from the fetal rat central nervous system. Brain Res. 1994 Apr 4;641(2):350–352. doi: 10.1016/0006-8993(94)90165-1. [DOI] [PubMed] [Google Scholar]
  42. Nakajima M., Kashiwagi K., Ohta J., Furukawa S., Hayashi K., Kawashima T., Hayashi Y. Nerve growth factor and epidermal growth factor rescue PC12 cells from programmed cell death induced by etoposide: distinct modes of protection against cell death by growth factors and a protein-synthesis inhibitor. Neurosci Lett. 1994 Aug 1;176(2):161–164. doi: 10.1016/0304-3940(94)90072-8. [DOI] [PubMed] [Google Scholar]
  43. Nitiss J., Wang J. C. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7501–7505. doi: 10.1073/pnas.85.20.7501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. O'Connor P. M., Kerrigan D., Bertrand R., Kohn K. W., Pommier Y. 10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells. Cancer Commun. 1990;2(12):395–400. doi: 10.3727/095535490820873912. [DOI] [PubMed] [Google Scholar]
  45. Oppenheim R. W. Cell death during development of the nervous system. Annu Rev Neurosci. 1991;14:453–501. doi: 10.1146/annurev.ne.14.030191.002321. [DOI] [PubMed] [Google Scholar]
  46. Perego P., Capranico G., Supino R., Zunino F. Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types. Anticancer Drugs. 1994 Dec;5(6):645–649. doi: 10.1097/00001813-199412000-00006. [DOI] [PubMed] [Google Scholar]
  47. Perry R. P., Kelley D. E. Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J Cell Physiol. 1970 Oct;76(2):127–139. doi: 10.1002/jcp.1040760202. [DOI] [PubMed] [Google Scholar]
  48. Petroski R. E., Geller H. M. Selective labeling of embryonic neurons cultured on astrocyte monolayers with 5(6)-carboxyfluorescein diacetate (CFDA). J Neurosci Methods. 1994 Apr;52(1):23–32. doi: 10.1016/0165-0270(94)90051-5. [DOI] [PubMed] [Google Scholar]
  49. Ratan R. R., Murphy T. H., Baraban J. M. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem. 1994 Jan;62(1):376–379. doi: 10.1046/j.1471-4159.1994.62010376.x. [DOI] [PubMed] [Google Scholar]
  50. Sarkander H. I., Dulce H. J. Studies on the regulation of RNA synthesis in neuronal and glial nuclei isolated from rat brain. Exp Brain Res. 1978 Mar 15;31(3):317–327. doi: 10.1007/BF00237292. [DOI] [PubMed] [Google Scholar]
  51. Soffer D., Grotsky H. W., Rapin I., Suzuki K. Cockayne syndrome: unusual neuropathological findings and review of the literature. Ann Neurol. 1979 Oct;6(4):340–348. doi: 10.1002/ana.410060407. [DOI] [PubMed] [Google Scholar]
  52. Solary E., Bertrand R., Kohn K. W., Pommier Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood. 1993 Mar 1;81(5):1359–1368. [PubMed] [Google Scholar]
  53. Squires S., Ryan A. J., Strutt H. L., Johnson R. T. Hypersensitivity of Cockayne's syndrome cells to camptothecin is associated with the generation of abnormally high levels of double strand breaks in nascent DNA. Cancer Res. 1993 May 1;53(9):2012–2019. [PubMed] [Google Scholar]
  54. Takei N., Endo Y. Ca2+ ionophore-induced apoptosis on cultured embryonic rat cortical neurons. Brain Res. 1994 Jul 25;652(1):65–70. doi: 10.1016/0006-8993(94)90317-4. [DOI] [PubMed] [Google Scholar]
  55. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 1995 Mar 10;267(5203):1456–1462. doi: 10.1126/science.7878464. [DOI] [PubMed] [Google Scholar]
  56. Tishler R. B., Calderwood S. K., Coleman C. N., Price B. D. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 1993 May 15;53(10 Suppl):2212–2216. [PubMed] [Google Scholar]
  57. Tomkins C. E., Edwards S. N., Tolkovsky A. M. Apoptosis is induced in post-mitotic rat sympathetic neurons by arabinosides and topoisomerase II inhibitors in the presence of NGF. J Cell Sci. 1994 Jun;107(Pt 6):1499–1507. doi: 10.1242/jcs.107.6.1499. [DOI] [PubMed] [Google Scholar]
  58. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Venema J., Mullenders L. H., Natarajan A. T., van Zeeland A. A., Mayne L. V. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4707–4711. doi: 10.1073/pnas.87.12.4707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Ventimiglia R., Geller H. M. Cell types and cell-substrate interactions in serum-free dissociated cultures of rat hypothalamus. Brain Res. 1987 Dec 15;436(2):339–351. doi: 10.1016/0006-8993(87)91677-5. [DOI] [PubMed] [Google Scholar]
  61. Vogel H., Horoupian D. S. Filamentous degeneration of neurons. A possible feature of cytosine arabinoside neurotoxicity. Cancer. 1993 Feb 15;71(4):1303–1308. doi: 10.1002/1097-0142(19930215)71:4<1303::aid-cncr2820710422>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  62. Walton M. I., Whysong D., O'Connor P. M., Hockenbery D., Korsmeyer S. J., Kohn K. W. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res. 1993 Apr 15;53(8):1853–1861. [PubMed] [Google Scholar]
  63. Wang J. C. DNA topoisomerases. Annu Rev Biochem. 1985;54:665–697. doi: 10.1146/annurev.bi.54.070185.003313. [DOI] [PubMed] [Google Scholar]
  64. Waser J., Hübscher U., Kuenzle C. C., Spadari S. DNA polymerase beta from brain neurons is a repair enzyme. Eur J Biochem. 1979 Jul;97(2):361–368. doi: 10.1111/j.1432-1033.1979.tb13122.x. [DOI] [PubMed] [Google Scholar]
  65. Winkelman M. D., Hines J. D. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Ann Neurol. 1983 Nov;14(5):520–527. doi: 10.1002/ana.410140505. [DOI] [PubMed] [Google Scholar]
  66. Wood K. A., Youle R. J. The role of free radicals and p53 in neuron apoptosis in vivo. J Neurosci. 1995 Aug;15(8):5851–5857. doi: 10.1523/JNEUROSCI.15-08-05851.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980 Apr 10;284(5756):555–556. doi: 10.1038/284555a0. [DOI] [PubMed] [Google Scholar]
  68. Wyllie A. H., Morris R. G., Smith A. L., Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984 Jan;142(1):67–77. doi: 10.1002/path.1711420112. [DOI] [PubMed] [Google Scholar]
  69. Zhang H., Wang J. C., Liu L. F. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1060–1064. doi: 10.1073/pnas.85.4.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES